<DOC>
	<DOCNO>NCT02017496</DOCNO>
	<brief_summary>The study explore safety breast conserve treatment ( BCT ) ( defined complete removal tumor deposit ) neoadjuvant treatment locally advance breast cancer .</brief_summary>
	<brief_title>Safety Breast Conserving Treatment Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment</brief_title>
	<detailed_description>The standard breast surgical procedure locally advance breast cancer Norway mastectomy . There increase interest perform breast conserving treatment ( BCT ) locally advanced case chemotherapy hormonal treatment - partial complete clinical remission . To increase evidence safety ( residual tumor ) procedure directly compare mastectomy without compromise safety treatment , breast preserving procedure follow immediate mastectomy perform within study . It would possible study margin breast preserving procedure well tumor status rest breast . Patients include study receive neoadjuvant treatment follow evaluation tumor reduction magnetic resonance imaging ( MRI ) selection BCT candidate . Candidates prepare BCT , surgical procedure , BCT perform ( one surgical specimen ) follow immediate removal rest breast tissue ( mastectomy ) . The BCT specimen mastectomy specimen analyse residual tumor cell . The tumor removal completeness BCT procedure evaluate , comparison clinical primary tumor characteristic , include analysis tumor biopsy image neoadjuvant treatment , selection candidate BCT future .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Inclusion criterion : Patients locally advance breast cancer ( cT34c , N03 ) tumor &gt; 5 cm , determine MRI , present guideline include neoadjuvant systemic therapy Written inform consent ( informed consent document approve Independent Ethics Committee ) prior studyrelated procedure examination . Female age &gt; 18 year Able comply protocol Histologically confirm adenocarcinoma breast American Society Anesthesiologist 's physical status category 1 2 surgery . Category 1 2 include healthy patient patient mild systemic disease , whereas category 3 include patient serious systemic disease ( still operable ) . Exclusion criterion : Inflammatory breast cancer diffuse locoregional involvement skin Stage IV metastatic disease Locoregional relapse earlier breast cancer Inability ( irrespective reason ) receive recommend neoadjuvant treatment , decide treat physician . American Society Anesthesiologist 's physical status category 45</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>locally advanced</keyword>
	<keyword>neoadjuvant treatment</keyword>
	<keyword>breast conserving surgery</keyword>
</DOC>